[ad_1]
• Continued acceleration in growth in Q3 2024: +20% overall and +30% in the United States
• Turnover up +13% over the first 9 months, to €3.6 million
PARIS, BOULDER (Colorado-United States), October 9, 2024 – 6:00 p.m. CEST – SpineGuard (FR0011464452 – ALSGD, PEA-PME eligible), innovative company which deploys its digital surgical guidance technology (DSG®) by local measurement of the electrical conductivity of tissues in real time to secure and simplify the placement of bone implants, announces its third quarter 2024 revenue.
To receive all of SpineGuard’s financial information in real time, request it by email to [email protected].
[ad_2]
Source link -86